ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FUM Futura Medical Plc

35.45
0.05 (0.14%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 0.14% 35.45 35.20 35.60 35.65 35.20 35.45 246,675 16:35:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -18.14 105.85M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 35.40p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £105.85 million. Futura Medical has a price to earnings ratio (PE ratio) of -18.14.

Futura Medical Share Discussion Threads

Showing 14051 to 14062 of 21425 messages
Chat Pages: Latest  569  568  567  566  565  564  563  562  561  560  559  558  Older
DateSubjectAuthorDiscuss
21/10/2022
11:43
Yes Broomrigg and despite LBOs frantic, repetitive efforts

He must be so bitter to be concentrating all his spite on a share which he doesn't even hold

mikethebike4
21/10/2022
10:28
Nice to see 40p bid :-)
broomrigg
20/10/2022
18:02
Heh heh heh!
petroc
20/10/2022
17:54
The only jumping going on is by the ramping liars like you. Who’s pants are on fire (and not just from rubbing alcohol and water on their brainless heads). But rather from continually being proven to be making false claims on ADVFN! LOL



The courts have crearly ruled its up to those making the false claims to be able to substantiate them. You have failed to substantiate that MED3000 ‘ it works’ beyond a placebo. As all of your’ plenty of evidence’ has been proven to be ˜deficient’ as it relies on inadequately controlled and unblinded studies.

The courts have also ruled that it is not required to prove that a product does not work in order to carry its burden that the sellers representations are false. As were your representations that ‘it works’ and claiming nobody can provide evidence to the contrary.

The courts also ruled to make claims like you have that ‘it works’ . When the only evidence you can rely on is deficient and just substantiates MED3000 is a acting as a placebo. Then again you have made more false and misleading claims on ADVFN.

And your fake defence that its up to others to carry out the adequately controlled study to be able to prove MED3000 works or doesn’t work. Is also ‘bunk’ according to the courts. They have clearly ruled its up to the advertisers to have done it before they can make claims like you did on ADVFN that ‘it works’

lbo
20/10/2022
17:27
Heh heh heh! You haven't asked me 'how high' yet because you already know! Keep jumping, LiarBO!
petroc
20/10/2022
17:05
How ironic mike you now accuse the scientists and Doctors of pulling the wool over investors eyes!mikethebike4 - 11 Apr 2018 - 14:35:10 - 4072 of 11141Having had similar waffling, 'smoke-screen' answers from Mr Barder over the years which have turned out to end in exactly nothing I am loathe to give any credence to virtually everything he saysmikethebike4 - 11 Apr 2018 - 15:58:28 - 4091 of 11141Company is massively over valued if you go by 'concrete' results !mikethebike4 - 11 Apr 2018 - 15:14:56 - 4082 of 11141I only try and bring some sort of balance into the equation to help the gullible not get carried away with fanciful future projections.I would like nothing better than to be proved wrong about Mr Barder (our CEO since 2001) and to sale away into the sunset grasping 5 times as many £s in my fist as I paid for the sharesUnfortunately for people like J7J, Mr Barder has been through this advisors process before - with CSD500 - and look where we've got in 17 years - sales of the product did not even equal the money we paid him to be our CEO for 2017 !mikethebike4 - 06 Dec 2017 - 10:32:27 - 3468 of 10591"A couple of decent deals and will be back off to the races."Do you have any idea of how long shareholders have been using these wordsmikethebike4 - 23 Mar 2017 - 09:52:33 - 2560 of 10591As someone who has been invested for many years and who attended an AGM years ago and complained to Barder about the very slow progress, I am very frustrated.All the time the Board are drawing good salaries off the backs of shareholders money they have very little incentive to get off their backsides and get 'selling' - thats what running a company is all about at the end of the day!mikethebike4 - 24 Feb 2020 - 09:11:58 - 7290 of 9713why should it be any different this time when you've still got the same useless lot running the showmikethebike4 - 07 Jan 2019 - 11:22:52 - 4692 of 9641I repeat I very much hope you are right - no one would be happier than me if you are - however I stupidly (in hindsight) bought in when everything looked really rosy - we were told there were loads of 'distributors' all 'champing at the bit to get selling a wonderful industry disruptive product (which it still is incidentally) once the 2 year shelf-life problem was fixed. This was despite the fact that the Holland/Belgium distributor was quite happy and successful selling them with the original 18 months shelf-lifeAnd where are we now years later - one tiny distributor from which Futura receives a total sales income only just about covering Mr Barders employment remunerationI just hope this MED/TPR situation is not just a repeat of CSD. As to why I don't just sell up, well my shareholding is worth such a tiny proportion of what I paid for it I might just as well hang on in the hope that new shareholders getting in now are luckier than I was and I can get some of my money back - I think what we need is Mr Barders retirement - that should give the share price a
lbo
20/10/2022
16:50
LOL

Now the ramper is claiming its naive to not believe uncontrolled studies that have not even been fully published and fully peer reviewed. But is naive to believe controlled studies that are fully published and open to full peer review! And is now claiming all the wider scientific and academics are pulling the wool over everyone’s eyes when recommending a drug with proven long term safety and efficacy rather then a medical device gel! Yet the ramper is the only one trying to pull the wool over the eyes of the naive investors he is trying to dupe into buying shares!





Devices are subject to weaker standards than drugs because they are regulated under a different law. The Medical Device Amendments of 1976 was intended to encourage innovation while allowing for a range of review standards based on risk, according to legal expert Richard A. Merrill. An array of corporate lobbying has since prompted Congress to ease regulations and make it easier for devices to get the FDA OK

Journalists need to scrutinize the claims
Journalists have a responsibility to report this lack of evidence, but they often dont. Investigative journalist Jeanne Lenzer, who wrote a book about the under-regulated medical device industry, says more dogged reporting is needed: We really dont know what we are getting with many of these devices

Ninety-nine percent of devices never have to provide clinical data, thanks in part to the 2002 Medical Devices User Fee Act, which requires the FDA to use the least burdensome route

For the few devices subject to a scientific review, the quality standards are flimsy. Randomized controlled trials, the gold standard, are infrequent. Most studies are unblinded, and thus prone to bias. The FDA settles for loosely defined reasonable assurance that a device is safe and effective, versus its higher standard of substantial evidence for drugs, which require studies with comparison groups that didnt receive the same treatment. Thus, data that would never be sufficient to support the approval of a drug can result in the approval of a device used to treat the same condition, potentially diverting patients from effective drugs to less-effective devices.



De Novo-winning devices often lack effectiveness data, analysis shows

lbo
20/10/2022
16:44
LBO you are so nieve anybody can pull the wool over your eyes - especially the so called scientists

not to mention the journalists !!!

mikethebike4
20/10/2022
16:17
So now the ramper is claiming that all these reputable organisations and Courts. Are not making objective judgments based on the scientific evidence but because they ‘have fingers in the pie’? LOL



A class 2 medical device gel which has no proven effect in any adequately controlled study. Is NOT a competitor to proven safe and effective oral PDE5I drugs. The oral drugs have proven efficacy beyond placebo in many adequately controlled studies and are the recommended first line therapy. Even in FM71 Med3000 was proven inferior in efficacy to Tadalafil and the only reported side effect were headaches and non cardiac chest pain. While MED3000 users also reported headaches and nausea and penile pain! And MED3000 is also a goopy messy and indiscreet gel. Just the same as using any arousal gel already on the market.

lbo
20/10/2022
13:46
Remember, the anonymity of the internet should make you sceptical of what anyone says if you don't know who they are. Therefore disregard anything that the stockbasher LiarBO posts, unless you know who he is. He once claimed that I was 'hiding behind anonymity' so I challenged him to reveal who he was, to no avail. Glass houses.
petroc
20/10/2022
13:14
And now the ramper who is not reflecting the wider scientific and academic community but rather just his pocket. Is now trying to claim the FTC, the ASA, the SMSNA and the courts are making judgments and rulings on false representations and trying to dupe others! LOL



What standards are applied to evidence? The position taken by the ASA is a tried and tested one which has developed over the course of many years. It reflects the opinion of the wider scientific and academic community, rather than judgements made solely by the ASA. There are many aspects that are taken into consideration when evidence is reviewed and each claim is judged on its merits alongside the evidence presented to support it. Evidence submitted for health claims should normally include at least one adequately controlled experimental human



Remember, the anonymity of the Internet should make you skeptical of what anyone says if you don’t t know who they are. Before making a buy or sell decision on a stock, make sure you are dealing with a reliable source. And if that source is an anonymous stock forum poster, that source is rarely reliable.

Here are 15 ways you can identify the stock discussion board ramper. I’ve seen the same behaviors in the stock rampers across many stock forums. Once you know the warning signs, you can learn to spot the ramper much more easily: They attack those who disagree with their lofty predictions. They cannot back up their arguments with a rational discussion, so they resort to petty name calling and telling others who disagree with them that they are ‘full of it’

lbo
18/10/2022
13:49
Careful LBO you're spouting rubbish again

It looks to me that you are suffering from one or more of those little blue pill side effects

or are all the side effects placebos as well ?

Keep taking the pills but don't rub them in too hard or long - or is that what you are trying to achieve ?

mikethebike4
Chat Pages: Latest  569  568  567  566  565  564  563  562  561  560  559  558  Older

Your Recent History

Delayed Upgrade Clock